First Clinical Results of a New Generation of Ablative Solid-State Lasers.
Bojan PajicBrigitte Pajic-EggspuehlerŽeljka CvejićChristian RathjenViktor RuffPublished in: Journal of clinical medicine (2023)
In the early 2000s, solid-state lasers emerged as an alternative technology to excimer systems in refractive surgery. Despite some technological limits at the time, good clinical results could be achieved with solid-state laser systems. This prospective case series reports clinical outcomes of five eyes treated with a newly developed solid-state laser system (AquariuZ) in three patients. Patients underwent preoperative examination, including corneal topo-and tomography, aberrometry, and confocal microscopy. All patients received a femtosecond LASIK with the Ziemer LDV Z8, a refractive treatment with the AquariuZ solid-state ablation laser, and were then followed up for a period of up to 12 months. The applied aspheric optimized profiles did not induce higher-order aberrations nor spherical aberration in any of these operated subjects. No eye lost BCVA lines throughout the duration of the follow-up. Six months after surgery, the safety index of patient 1 was 5, and for patients 2 and 3, it equaled 1. Confocal laser microscopy imaging findings were comparable to those seen typically for excimer lasers. The obtained results are encouraging and confirm that the new solid-state laser system is safe.
Keyphrases
- solid state
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- optical coherence tomography
- prognostic factors
- high resolution
- patient reported outcomes
- emergency department
- atrial fibrillation
- gene expression
- patients undergoing
- dna methylation
- case report
- genome wide
- coronary artery disease
- single molecule
- percutaneous coronary intervention
- single cell